These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 28289095)

  • 1. Contribution of type III interferons to antiviral immunity: location, location, location.
    Kotenko SV; Durbin JE
    J Biol Chem; 2017 May; 292(18):7295-7303. PubMed ID: 28289095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-λs.
    Kotenko SV
    Curr Opin Immunol; 2011 Oct; 23(5):583-90. PubMed ID: 21840693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unique regulation and functions of type III interferons in antiviral immunity.
    Odendall C; Kagan JC
    Curr Opin Virol; 2015 Jun; 12():47-52. PubMed ID: 25771505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type III Interferons in Viral Infection and Antiviral Immunity.
    Zhou JH; Wang YN; Chang QY; Ma P; Hu Y; Cao X
    Cell Physiol Biochem; 2018; 51(1):173-185. PubMed ID: 30439714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type III interferons in innate and adaptive immunity in the respiratory tract.
    Piperakis A; Galani IE; Andreakos E
    Curr Opin Immunol; 2024 Apr; 87():102430. PubMed ID: 38824869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type III IFNs: Beyond antiviral protection.
    Kotenko SV; Rivera A; Parker D; Durbin JE
    Semin Immunol; 2019 Jun; 43():101303. PubMed ID: 31771761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces.
    Stanifer ML; Guo C; Doldan P; Boulant S
    Front Immunol; 2020; 11():608645. PubMed ID: 33362795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections.
    Lin JD; Feng N; Sen A; Balan M; Tseng HC; McElrath C; Smirnov SV; Peng J; Yasukawa LL; Durbin RK; Durbin JE; Greenberg HB; Kotenko SV
    PLoS Pathog; 2016 Apr; 12(4):e1005600. PubMed ID: 27128797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type III and Not Type I Interferons Efficiently Prevent the Spread of Rotavirus in Human Intestinal Epithelial Cells.
    Doldan P; Dai J; Metz-Zumaran C; Patton JT; Stanifer ML; Boulant S
    J Virol; 2022 Sep; 96(17):e0070622. PubMed ID: 36000839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shared and Distinct Functions of Type I and Type III Interferons.
    Lazear HM; Schoggins JW; Diamond MS
    Immunity; 2019 Apr; 50(4):907-923. PubMed ID: 30995506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What have we learned from the IL28 receptor knockout mouse?
    Mordstein M; Michiels T; Staeheli P
    J Interferon Cytokine Res; 2010 Aug; 30(8):579-84. PubMed ID: 20649452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of Type III Interferon (IFN) Genes
    Peterson ST; Kennedy EA; Brigleb PH; Taylor GM; Urbanek K; Bricker TL; Lee S; Shin H; Dermody TS; Boon ACM; Baldridge MT
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-λ in the context of viral infections: production, response and therapeutic implications.
    Hermant P; Michiels T
    J Innate Immun; 2014; 6(5):563-74. PubMed ID: 24751921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral activity of type I interferons and interleukins 29 and 28a (type III interferons) against Apeu virus.
    Almeida GM; de Oliveira DB; Magalhães CL; Bonjardim CA; Ferreira PC; Kroon EG
    Antiviral Res; 2008 Dec; 80(3):302-8. PubMed ID: 18657576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial pathogenesis and type III interferons.
    Cohen TS; Parker D
    Cytokine Growth Factor Rev; 2016 Jun; 29():45-51. PubMed ID: 26987613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control.
    Andreakos E; Zanoni I; Galani IE
    Curr Opin Immunol; 2019 Feb; 56():67-75. PubMed ID: 30399529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type III interferons (IFNs): Emerging Master Regulators of Immunity.
    Galani IE; Koltsida O; Andreakos E
    Adv Exp Med Biol; 2015; 850():1-15. PubMed ID: 26324342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpesviruses and the Type III Interferon System.
    Yin Y; Favoreel HW
    Virol Sin; 2021 Aug; 36(4):577-587. PubMed ID: 33400088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.